Ozempic and Mounjaro have historically been difficult to keep in stock, though manufacturers are working to increase supply
Here are some key points to remember: Stick to your schedule : Choose a specific day and time for your injections to build a routine
Is There a Safer Alternative to Mounjaro
The trial data shows slightly higher hair loss rates with tirzepatide (about 5%) versus semaglutide (about 3%), but tirzepatide also produces more weight loss, which to me is the more likely explanation
Hepatic Uncommon (0.1% to 1%): Acute gallbladder disease (cholelithiasis, biliary colic, cholecystectomy) Hypersensitivity Common (1% to 10%): Hypersensitivity reactions (e.g., urticaria, eczema) Postmarketing reports : Anaphylaxis, angioedema Immunologic Very common (10% or more): Anti-drug antibodies (up to 51%) Common (1% to 10%): Neutralizing antibodies Local Common (1% to 10%): Injection site reactions Metabolic Very common (10% or more): Hypoglycemia (up to 19%), decreased appetite (up to 11%) Common (1% to 10%): Hyperglycemia Hypoglycemia (glucose level less than 54 mg/dL) occurred more frequently when this drug was used in combination with a sulfonylurea (up to 13% of patients in a clinical trial)
